Healome Therapeutics Secures £2M to Advance Eye Drop Technology
BIRMINGHAM, United Kingdom, July 7, 2026 Healome Therapeutics, a University of Birmingham spinout developing an innovative eye-drop matrix technology...
Investment Fund
Advertisement
Regal Healthcare Capital Closes $610 Million Fund IV
NEW YORK, July 7, 2026 Regal Healthcare Capital Partners has successfully completed the final close of Fund IV, securing...
CARsgen Reports Promising Allogeneic CAR-T Data at EHA
SHANGHAI, China, June 15, 2026 CARsgen Therapeutics Holdings Limited has unveiled encouraging clinical data for its investigational allogeneic CAR...
Kos Biotechnology Partners Closes $123M Life Sciences Fund
NEW YORK and ATHENS, Greece, June 13, 2026 Kos Biotechnology Partners has announced the successful third closing of its...
Advertisement
